Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis

by Yantao Xu, Zixi Jiang, Xinwei Kuang, Xiang Chen, Hong Liu
Published 2022-06-01

Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation

by Jing Liu, Hong Liu, Hui Li, Mao Ye, Lin Zhu, Xiang Chen, Bin Hu, Dandan Liu, Long Liang, Xinwei Kuang, Guanxiong Zhang, Zuozhong Xie
Published 2022-05-01

The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD‐L1

by Hui Li, Xinwei Kuang, Long Liang, Youqiong Ye, YongChang Zhang, Jialu Li, Fangyu Ma, Juan Tao, Guang Lei, Shuang Zhao, Juan Su, Nong Yang, Cong Peng, Xiaowei Xu, Mien‐Chie Hung, Leng Han, Hong Liu, Jing Liu, Xiang Chen
Published 2021-01-01

Profiling of immune features to predict immunotherapy efficacy

by Youqiong Ye, Yongchang Zhang, Nong Yang, Qian Gao, Xinyu Ding, Xinwei Kuang, Rujuan Bao, Zhao Zhang, Chaoyang Sun, Bingying Zhou, Li Wang, Qingsong Hu, Chunru Lin, Jianjun Gao, Yanyan Lou, Steven H. Lin, Lixia Diao, Hong Liu, Xiang Chen, Gordon B. Mills, Leng Han
Published 2022-01-01

Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1

by Youqiong Ye, Xinwei Kuang, Zuozhong Xie, Long Liang, Zhao Zhang, Yongchang Zhang, Fangyu Ma, Qian Gao, Ruimin Chang, Heng-Huan Lee, Shuang Zhao, Juan Su, Hui Li, Jingbo Peng, Huifang Chen, Minzhu Yin, Cong Peng, Nong Yang, Jing Wang, Jing Liu, Hong Liu, Leng Han, Xiang Chen
Published 2020-09-01